相关实验视频
Updated: May 5, 2026

11:45
Quantifying Agonist Activity at G Protein-coupled Receptors
Published on: December 26, 2011
18.5K
激动剂和部分激动剂对β(1) -上腺素受体的作用的结构基础
Tony Warne1, Rouslan Moukhametzianov, Jillian G Baker
1MRC Laboratory of Molecular Biology, Hills Road, Cambridge CB2 0QH, UK.
Nature
|January 14, 2011
概括
结构洞察力揭示了不同的配体如何激活β-上腺素受体 (βARs). 完全激动剂与部分激动剂不同,结合关键的血清残留物,解释了喘和高血压等疾病的多种治疗作用.
科学领域:
- 结构生物学是结构生物学.
- 药理学 药理学是指药理学的学科.
- 生物化学 生物化学
背景情况:
- β-上腺素受体 (βARs) 是G蛋白合受体 (GPCRs),对生理反应至关重要.
- 针对βARs的合成配体用于治疗喘,高血压和心脏功能障碍.
- 了解连接剂有效性的结构基础对于药物开发至关重要.
研究的目的:
- 阐明βAR连接体不同功效的基础结构机制.
- 为合理设计新型GPCR向治疗提供结构性基础.
主要方法:
- 使用X射线晶体学来确定一个热稳定的火β(1) -上腺素受体 (β(1) AR-m23) 的结构.
- 获得了受体结合完全主动剂 (卡尔莫特醇,异上腺素) 和部分主动剂 (萨尔布塔摩尔,多布塔明) 的结构.
主要成果:
- 与对抗剂结合的状态相比,对抗剂结合的状态诱导了甲醇胺结合口袋的1%收缩.
- 完整的激动剂在跨膜螺旋中与两个保存的血清残留物 (Ser5.42和Ser5.46) 形成键.
- 部分激动剂只与Ser{5.42) 形成键,从而使它们的相互作用模式有所区别.
结论:
- 这项研究揭示了与联结剂在βARs中的疗效相关的明显的结构相互作用.
- 这些发现揭示了GPCR的功能,并为具有量身定制的药理特征的配体的基于结构的设计提供了基础.
相关概念视频
Drug-Receptor Interaction: Agonist
4.3K
Agonists are drugs that interact with specific receptors in the body to produce a biological response. When an agonist binds to a receptor, it activates or enhances the receptor's function, leading to physiological effects. The interaction between agonist drugs and receptors is crucial for their therapeutic action in various medical treatments.
Agonists can bind to receptors in different ways. Some agonists bind directly to the receptor's active site, mimicking the endogenous...
Agonists can bind to receptors in different ways. Some agonists bind directly to the receptor's active site, mimicking the endogenous...
4.3K
Adrenergic Receptors (Adrenoceptors): Classification
4.9K
Adrenergic receptors, or adrenoceptors, respond to the autonomic neurotransmitter noradrenaline and other endogenous catecholamine agonists. They are classified into two main families, α and β, based on their pharmacological response and are further subdivided depending on their location, elicited response, and affinity to specific agonists or antagonists.
α-Adrenoceptors
α-Adrenoceptors are classified into two main subtypes: α1 and α2. The α1 adrenoceptors,...
α-Adrenoceptors
α-Adrenoceptors are classified into two main subtypes: α1 and α2. The α1 adrenoceptors,...
4.9K
Adrenergic Receptors: ɑ Subtype
2.7K
Adrenoceptors are classified into α and ꞵ classes based on their potencies to catecholamine agonists. α-adrenoceptors show the following order of catecholamine potency:
Adrenaline ≥ Noradrenaline >> Isoprenaline
α-adrenoceptors are further divided into α1 and α2-adrenoceptors.
α1-Adrenoceptors: These receptors are located postsynaptically on the effector organs and cause constriction of smooth muscle mediated by activation of phospholipase...
Adrenaline ≥ Noradrenaline >> Isoprenaline
α-adrenoceptors are further divided into α1 and α2-adrenoceptors.
α1-Adrenoceptors: These receptors are located postsynaptically on the effector organs and cause constriction of smooth muscle mediated by activation of phospholipase...
2.7K
Adrenergic Receptors: β Subtype
3.8K
β-adrenoceptors have varied sensitivities towards adrenaline, noradrenaline, and isoprenaline. The order of agonist potency is as follows:
Isoprenaline > Adrenaline > Noradrenaline
Neurotransmitter binding to these receptors causes activation of adenylyl cyclase resulting in increased concentrations of cAMP and modulation of calcium ion channels within the cell. They are further classified into β1, β2, and β3 subtypes.
β1-adrenoceptors: β1-adrenoceptors...
Isoprenaline > Adrenaline > Noradrenaline
Neurotransmitter binding to these receptors causes activation of adenylyl cyclase resulting in increased concentrations of cAMP and modulation of calcium ion channels within the cell. They are further classified into β1, β2, and β3 subtypes.
β1-adrenoceptors: β1-adrenoceptors...
3.8K
Adrenergic Agonists: Chemistry and Structure-Activity Relationship
3.9K
Adrenergic agonists' structure-activity relationship (SAR) determines their selectivity and efficacy. These agonists comprise a phenylethylamine moiety with an aromatic ring and an ethylamine side chain.
Aromatic ring substitutions: Substituting the aromatic ring with –OH groups at positions 3 and 4 yields catecholamines (e.g., epinephrine), which have a high affinity for adrenoceptors. Hydrogen bonding between –OH groups and receptors enhances adrenergic activity.
Separation of...
Aromatic ring substitutions: Substituting the aromatic ring with –OH groups at positions 3 and 4 yields catecholamines (e.g., epinephrine), which have a high affinity for adrenoceptors. Hydrogen bonding between –OH groups and receptors enhances adrenergic activity.
Separation of...
3.9K
Adrenergic Antagonists: Chemistry and Classification of ɑ-Receptor Blockers
1.7K
Adrenergic antagonists, or sympatholytics, inhibit adrenoceptor activation driven by catecholamines or agonists. Based on their adrenoceptor specificity, adrenergic blockers can be categorized into two primary groups: α-adrenergic blockers (α-blockers) and β-adrenergic blockers (β-blockers). α-blockers interact with α1 and α2 subtypes of α-adrenoceptors.
Nonselective α-blockers: Nonselective α-blockers contain haloalkylamine or imidazoline...
Nonselective α-blockers: Nonselective α-blockers contain haloalkylamine or imidazoline...
1.7K

